Functional Genetic Variation in the Basal Promoter of the Organic Cation/Carnitine Transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)
暂无分享,去创建一个
P. Kwok | T. Ferrin | K. Giacomini | S. Yee | S. Johns | S. Hesselson | R. Castro | D. Stryke | M. Kawamoto | T. Urban | Harunobu Tahara
[1] K. Giacomini,et al. Genetic Variation in Drug Transporters in Ethnic Populations , 2008, Clinical pharmacology and therapeutics.
[2] W. Sadee,et al. Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. , 2008, Blood.
[3] O. Ogawa,et al. Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney , 2008, Journal of Human Genetics.
[4] P. Watkins,et al. Association of Breast Cancer Resistance Protein/ABCG2 Phenotypes and Novel Promoter and Intron 1 Single Nucleotide Polymorphisms , 2008, Drug Metabolism and Disposition.
[5] E. Burchard,et al. Effects of Genetic Variation in the Novel Organic Cation Transporter, OCTN1, on the Renal Clearance of Gabapentin , 2008, Clinical pharmacology and therapeutics.
[6] K. Giacomini,et al. Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics , 2008, Clinical pharmacology and therapeutics.
[7] Conrad C. Huang,et al. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). , 2007, Pharmacogenetics and genomics.
[8] Z. Tulassay,et al. Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes , 2007, British Journal of Nutrition.
[9] S. Vavricka,et al. Regional Distribution of Solute Carrier mRNA Expression Along the Human Intestinal Tract , 2007, Drug Metabolism and Disposition.
[10] K. Miyazawa,et al. Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines , 2007, Drug Metabolism and Disposition.
[11] R B Altman,et al. The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response , 2007, Clinical pharmacology and therapeutics.
[12] Judy H. Cho,et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease , 2007, European Journal of Human Genetics.
[13] E. Burchard,et al. Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) , 2006, Molecular Pharmacology.
[14] S. Higuchi,et al. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy , 2006, Expert opinion on drug metabolism & toxicology.
[15] J. Verweij,et al. Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study. , 2006, The oncologist.
[16] D. Rosskopf,et al. Uptake of Cardiovascular Drugs Into the Human Heart: Expression, Regulation, and Function of the Carnitine Transporter OCTN2 (SLC22A5) , 2006, Circulation.
[17] Michel Eichelbaum,et al. Pharmacogenomics and individualized drug therapy. , 2006, Annual review of medicine.
[18] J. Castle,et al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition , 2006, Xenobiotica; the fate of foreign compounds in biological systems.
[19] R. Myers,et al. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. , 2005, Genome research.
[20] M. Nishimura,et al. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. , 2005, Biological & pharmaceutical bulletin.
[21] Bill Newman,et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease , 2004, Nature Genetics.
[22] H. Koepsell,et al. The SLC22 drug transporter family , 2004, Pflügers Archiv.
[23] Yusuke Nakamura,et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.
[24] Peter Donnelly,et al. A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.
[25] Conrad C. Huang,et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] I. Tein. Carnitine transport: Pathophysiology and metabolism of known molecular defects , 2003, Journal of Inherited Metabolic Disease.
[27] G. Mitchell,et al. Carnitine transport by organic cation transporters and systemic carnitine deficiency. , 2001, Molecular genetics and metabolism.
[28] J. Nezu,et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. , 2001, Molecular pharmacology.
[29] V. Ganapathy,et al. β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter* , 2000, The Journal of Biological Chemistry.
[30] Y. Matsuzawa,et al. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency. , 1998, Journal of molecular and cellular cardiology.
[31] Y. Kato,et al. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart. , 2008, Drug metabolism and pharmacokinetics.
[32] H. Hasegawa,et al. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. , 2008, Drug metabolism and pharmacokinetics.
[33] Rui Gao,et al. Pharmacogenetics of membrane transporters: a review of current approaches. , 2008, Methods in molecular biology.
[34] M. Nishimura,et al. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. , 2005, Drug metabolism and pharmacokinetics.
[35] J. Nezu,et al. Molecular and Physiological Evidence for Multifunctionality of Carnitine / Organic Cation Transporter OCTN 2 , 2001 .